• Exchange: New York
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Large Pharmaceuticals

PFE:US

30.2500 USD 0.1600 0.53%

As of 20:04:04 ET on 04/17/2014.

Snapshot for Pfizer Inc (PFE)

Open: 30.1500 Day's Range: 30.0700 - 30.4000 Volume: 26,536,813
Previous Close: 30.0900 52wk Range: 27.1200 - 32.9600 1-Yr Rtn: +2.17%

Stock Chart for PFE

No chart data available.
  • PFE:US 30.2500
  • 1D
  • 1M
  • 1Y
30.0900
Interactive PFE Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for PFE

Current P/E Ratio (ttm) 13.1165
Estimated P/E(12/2014) 13.5772
Relative P/E vs. SPX 0.7627
Earnings Per Share (USD) (ttm) 2.3063
Est. EPS (USD) (12/2014) 2.2280
Est. PEG Ratio 3.1334
Market Cap (M USD) 193,404.25
Shares Outstanding (M) 6,393.53
30 Day Average Volume 29,421,644
Price/Book (mrq) 2.5378
Price/Sale (ttm) 3.9052
Dividend Indicated Gross Yield 3.44%
Cash Dividend (USD) 0.2600
Dividend Ex-Date 02/05/2014
5 Year Dividend Growth -5.20%
Next Earnings Announcement 05/05/2014
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for PFE

  • Revenue
  • Net Income (M/USD)
  • Profit Margin (%)

Company Profile & Key Executives for PFE

Pfizer Inc. is a research-based, global pharmaceutical company that discovers, develops, manufactures, and markets medicines for humans and animals. The Company's products include prescription pharmaceuticals, non-prescription self-medications, and animal health products such as anti-infective medicines and vaccines.

Ian C ReadChairman/CEOGeno J GermanoPres:Global Innovative Pharma
Albert BourlaPres:Vaccines & OncologyMikael DolstenPres:Worldwide Research & Dev
More Company Profile & Key Executives for PFE

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil